InMode (INMD) Non-Current Assets (2018 - 2026)
InMode (INMD) posted quarterly Non-Current Assets of $70.1 million for Q1 2026, little changed year-on-year from $70.1 million in Q1 2025, and up 3.32% on a QoQ basis from $67.8 million in Q4 2025.
InMode (INMD) Non-Current Assets (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Non-Current Assets for 9 consecutive years, with $70.1 million the latest figure, recorded in Q1 2026.
- Quarterly Non-Current Assets changed 0.06% year-over-year to $70.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.1 million (changed 0.06% YoY) and the FY2025 annual result came in at $67.8 million, down 4.78% from the prior year.
- Non-Current Assets rose to $70.1 million in Q1 2026 per INMD's latest filing, from $67.8 million in the prior quarter.
- Over the last five years, Non-Current Assets for INMD reached as high as $71.2 million in Q4 2024 and fell as low as $9.6 million in Q1 2022.
- A 5-year average of $34.3 million and a median of $16.8 million in 2024 frame the typical range for Non-Current Assets.
- The largest YoY upside for Non-Current Assets was 336.87% in 2025 against a maximum downside of 4.78% in 2025.
- Year by year, Non-Current Assets stood at $15.0 million in 2022, then advanced by 19.4% to $18.0 million in 2023, then surged by 296.61% to $71.2 million in 2024, then decreased by 4.78% to $67.8 million in 2025, then gained by 3.32% to $70.1 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $70.1 million, $67.8 million, and $68.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 70.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.06 Mn |
| Dec 31, 2025 | 67.81 Mn |
| Sep 30, 2025 | 68.31 Mn |
| Jun 30, 2025 | 69.57 Mn |
| Mar 31, 2025 | 70.10 Mn |
| Dec 31, 2024 | 71.22 Mn |
| Sep 30, 2024 | 15.64 Mn |
| Jun 30, 2024 | 16.84 Mn |
| Mar 31, 2024 | 17.55 Mn |
| Dec 31, 2023 | 17.96 Mn |
| Sep 30, 2023 | 15.62 Mn |
| Jun 30, 2023 | 14.88 Mn |
| Mar 31, 2023 | 14.68 Mn |
| Dec 31, 2022 | 15.04 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 14.00 Mn |
| Mar 31, 2022 | 9.62 Mn |
| Dec 31, 2021 | 8.43 Mn |
| Sep 30, 2021 | 7.67 Mn |
| Jun 30, 2021 | 7.69 Mn |